# Fatty Liver trials recruiting, no drug phase: 31 (2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 31 trials with no drug phase for Fatty Liver that are recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Recruiting Fatty Liver trials with no drug phase: 31 rows for $5, recruiting or not yet recruiting on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. The new rows each week by email, about 1 row a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/recruiting/not-applicable/fatty-liver

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 31
- Recruiting or not yet: 31
- Read on: November 19, 2026

## Trials

The 25 newest of 31, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| November 6, 2026 | NCT07922720 | Efficacy of Carnitine Complex in Improving Hepatic Steatosis in Potential Liver Donors | Samsung Medical Center | Not applicable | Not yet recruiting | Hepatic Steatosis, Fatty Liver, Non-Alcoholic Fatty Liver Disease, Metabolic Dysfunction-Associated Steatotic Liver... | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07922720) |
| August 26, 2026 | NCT07786831 | Dietary Intervention Study on Liver Health in Young Adults | Hochschule Campus Wien (University of Applied Sciences Campus Vienna) | Not applicable | Recruiting | Liver Health | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07786831) |
| August 12, 2026 | NCT07760909 | Metabolic Flux Analysis in Metabolic Dysfunction-Associated Steatotic Liver Disease | Vanderbilt University Medical Center | Not applicable | Not yet recruiting | Metabolic Dysfunction-Associated Steatotic Liver Disease, Metabolic Dysfunction-Associated Steatohepatitis, Obesity... | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07760909) |
| July 9, 2026 | NCT07692438 | Taiwan Green Propolis for Blood Lipids and Body Fat in Patients With MASLD | Taipei Medical University | Not applicable | Recruiting | Metabolic Dysfunction-Associated Steatotic Liver Disease, Non-alcoholic Fatty Liver Disease NAFLD, Dyslipidemia... | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07692438) |
| June 12, 2026 | NCT07646197 | Effects of Peanut Consumption on Adults With Metabolic Associated Fatty Liver Disease | Henry Ford Health System | Not applicable | Recruiting | MASLD, Fatty Liver | 125 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07646197) |
| March 27, 2026 | NCT07495332 | Siemens Biomarker Multi-modality | Duke University | Not applicable | Recruiting | Fatty Liver, Hepatic Steatosis | 45 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07495332) |
| February 10, 2026 | NCT07400367 | Impact of a Probiotic Supplementation With Lifestyle Modification on Liver Steatosis, Fibrosis, and Metabolic Health in Patients With... | Fu Jen Catholic University Hospital | Not applicable | Recruiting | Liver Elastography, Liver Steatosis, Liver Function Test, Insulin Resistance, Cardiometabolic Risk Factors | 80 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07400367) |
| February 10, 2026 | NCT07399600 | Personalized Transcranial Magnetic Stimulation (TMS) for Metabolic Dysfunction and Alcohol-Related Liver Disease | The Affiliated Hospital of Hangzhou Normal University | Not applicable | Not yet recruiting | Liver Diseases, Alcoholic, Fatty Liver, Metabolic Syndrome | 105 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07399600) |
| January 29, 2026 | NCT07376226 | Effects of Whole Fruit on Blood Sugar in People With Type 2 Diabetes | Harvard School of Public Health (HSPH) | Not applicable | Not yet recruiting | Type 2 Diabetes | 25 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07376226) |
| December 16, 2025 | NCT07285135 | Dietary Glycine Supplementation in Metabolic Dysfunction-associated Steatotic Liver Disease | Singapore General Hospital | Not applicable | Recruiting | Metabolic Dysfunction Associated Fatty Liver Disease | 90 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07285135) |
| December 8, 2025 | NCT07270601 | Development of a Quantifiable Ultrasound Biomarker for Hepatic Steatosis | ContextVision AB | Not applicable | Recruiting | MASLD - Metabolic Dysfunction-Associated Steatotic Liver Disease, NAFLD - Non-Alcoholic Fatty Liver Disease | 110 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07270601) |
| November 28, 2025 | NCT07254533 | Diagnosis and Quantification of Hepatic Steatosis Using Near-infrared Spectroscopy | Assistance Publique Hopitaux De Marseille | Not applicable | Not yet recruiting | Hepatic Transplantation, Steatohepatitis | 90 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07254533) |
| July 16, 2025 | NCT07068191 | Gepaktiv vs UDCA and Ademetionine in MAFLD With Hepatomegaly | Phenomen Pharma | Not applicable | Recruiting | Metabolic Dysfunction-associated Fatty Liver Disease (MAFLD), Hepatomegaly, Nonalcoholic Fatty Liver (NAFL)... | 90 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07068191) |
| June 10, 2025 | NCT07013916 | Fructose is a Metabolic and Inflammatory Pathogenic Factor in Metabolic Dysfunction-associated Steatohepatitis (MASH) | Queen Mary University of London | Not applicable | Recruiting | MASH - Metabolic Dysfunction-Associated Steatohepatitis, MASH With Fibrosis, Steatosis of Liver | 72 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07013916) |
| May 28, 2025 | NCT06993454 | Acute Exercise and Endogenous Glucose Production in Type 2 Diabetes: Implications for Glycemic Control and Treatment of Hepatic Steatosis | AdventHealth Translational Research Institute | Not applicable | Recruiting | Type 2 Diabetes, Hepatic Steatosis | 12 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06993454) |
| March 12, 2025 | NCT06873412 | Effects of Compound Probiotics-Polygonatum Sibiricum on Liver Health and Metabolism in Middle-aged and Elderly People | Wecare Probiotics Co., Ltd. | Not applicable | Not yet recruiting | Fatty Liver | 84 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06873412) |
| February 24, 2025 | NCT06843148 | Stimulating Fat Tissue Storage With Niacin to Reduce Fat Accumulation in the Liver. | Université de Sherbrooke | Not applicable | Recruiting | Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD), Liver Fibrosis/NASH, Non-Alcoholic Steato-Hepatitis... | 36 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06843148) |
| December 27, 2024 | NCT06748963 | Fasted Exercise Training in Type 1 Diabetes (FED-T1D) | University of Alberta | Not applicable | Recruiting | Diabetes Mellitus, Type 1 | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06748963) |
| October 28, 2024 | NCT06661655 | Evaluation of a New Ultrasound System for the Non-invasive Assessment of Liver Steatosis in MASLD/MASH Patients | E-Scopics | Not applicable | Recruiting | Metabolic Syndrome X, Fatty Liver, MASH - Metabolic Dysfunction-Associated Steatohepatitis, MASLD, NASH (Non-Alcoholic... | 120 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06661655) |
| August 9, 2024 | NCT06546384 | GLP-1 RA on Alcohol Consumption, Metabolism and Liver Parameters in Patients With Obesity and Fatty Liver Disease | Insel Gruppe AG, University Hospital Bern | Not applicable | Not yet recruiting | Adiposity, Fatty Liver, Alcohol Use Disorder | 64 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06546384) |
| August 5, 2024 | NCT06537466 | Ketogenic Diet in MASLD-related cACLD | University of Palermo | Not applicable | Not yet recruiting | Steatohepatitis, Nonalcoholic, Steatosis of Liver, Cirrhosis, Liver | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06537466) |
| June 6, 2024 | NCT06446908 | Acceptability and Feasibility of a New Approach to Engage Patients With Steatotic Liver Disease in Physical Activity | Hopital Montfort | Not applicable | Not yet recruiting | Liver Steatosis, MASH, MASLD | 12 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06446908) |
| March 26, 2024 | NCT06329544 | High Fructose Diet, the Gut Microbiome, and Metabolic Health | Icahn School of Medicine at Mount Sinai | Not applicable | Recruiting | MASLD, Type 2 Diabetes, Obesity | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06329544) |
| January 18, 2024 | NCT06211556 | Depletion of Liver Fat in Type 2 Diabetes | Copenhagen University Hospital, Rigshospitalet | Not applicable | Recruiting | Type2diabetes, Obesity | 42 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06211556) |
| January 12, 2024 | NCT06203548 | Monitoring Changes in Hepatic Steatosis Using Continuous Controlled Attenuation Parameter | Chinese University of Hong Kong | Not applicable | Recruiting | Fatty Liver | 150 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06203548) |

## Sponsors with the most

| Sponsor | Trials |
| --- | --- |
| The University of Hong Kong | 1 |
| Harvard School of Public Health (HSPH) | 1 |
| Icahn School of Medicine at Mount Sinai | 1 |
| Singapore General Hospital | 1 |
| Fu Jen Catholic University Hospital | 1 |
| University Hospital, Ghent | 1 |
| Assistance Publique Hopitaux De Marseille | 1 |
| Queen Mary University of London | 1 |
| Université de Sherbrooke | 1 |
| Hochschule Campus Wien (University of Applied Sciences Campus Vienna) | 1 |
| Vanderbilt University Medical Center | 1 |
| Copenhagen University Hospital, Rigshospitalet | 1 |
| Henry Ford Health System | 1 |
| University of Oxford | 1 |
| University of Alberta | 1 |
| The Affiliated Hospital of Hangzhou Normal University | 1 |
| Duke University | 1 |
| Hopital Montfort | 1 |
| Chinese University of Hong Kong | 1 |
| Samsung Medical Center | 1 |
| University of Palermo | 1 |
| ContextVision AB | 1 |
| [Wecare Probiotics Co., Ltd.](https://specstream.ai/data/clinical-trials/company/wecare-probiotics-co-ltd) | 1 |
| AdventHealth Translational Research Institute | 1 |
| Massachusetts General Hospital | 1 |

## By country

| Country | Trials |
| --- | --- |
| United States | 8 |
| Canada | 3 |
| Hong Kong | 2 |
| Taiwan | 2 |
| France | 2 |
| United Kingdom | 2 |
| Singapore | 1 |
| Belgium | 1 |
| Austria | 1 |
| Denmark | 1 |
| China | 1 |
| Italy | 1 |
| Russia | 1 |
| Switzerland | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Beverage suppliers in the United States](https://specstream.ai/data/businesses/beverage-suppliers/united-states)
- [Cardiology practices in the United States](https://specstream.ai/data/businesses/cardiology-practices/united-states)
- [Commercial printers in the United States](https://specstream.ai/data/businesses/commercial-printers/united-states)
- [Dentistry schools in the United States](https://specstream.ai/data/businesses/dentistry-schools/united-states)
- [Elementary schools in the United States](https://specstream.ai/data/businesses/elementary-schools/united-states)
- [Fence contractors in the United States](https://specstream.ai/data/businesses/fence-contractors/united-states)
